wellrank.ai
Sign In
Noom logo

Noom

First cited by AI Jun 11, 2026
noom.com ↗

Surfaced organically in AI answers about glp-1 weight loss. Not yet profiled.

AI Visibility

Visibility trend

GLP-1 weight loss, daily share of AI answers mentioning Noom, through Oct 28, 2026.

27.8%

Avg position when mentioned: 1.8 · peak 50% on Oct 1

By engine

Where Noom is strong, and where it is invisible.

  • ChatGPT
    33.3%
  • Claude
    22.2%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 333 positive mentions
  • 101 neutral
  • 8 mixed or cautious

Recent AI answers mentioning Noom

ClaudeOct 28, 2026, 21:03 UTC
Has anyone had a good experience getting Wegovy through an online clinic?

Yes, there are several online clinics where people have reported good experiences getting Wegovy: Well-Regarded Options Ro Body Program Comprehensive support including health coaching Transparent pricing and insurance assistance help Strong reputation for follow-through Hims & Hers Easy-to-use platform Competitive pricing Good for people who want a straightforward process Noom Med Combines medication with their behavioral coaching app Good if you want lifestyle support alongside medication Found Focuses on personalized obesity treatment Includes coaching and community support Things to Keep in Mind Insurance coverage varies significantly - many of these clinics can help you navigate prior authorizations Supply shortages have been an ongoing issue with Wegovy specifically Some clinics may offer compounded semaglutide if brand-name is unavailable - make sure you understand what you're getting Legitimate clinics require a real medical consultation - be cautious of any that skip this step Tip Check if the clinic has board-certified physicians and clear follow-up care, not just a one-time prescription. Would you like more details about pricing or what the process typically looks like?

Mentioned in position 3 of 4

Read full answer with sources →
ChatGPTOct 28, 2026, 21:02 UTC
What is the best telehealth option for menopause weight gain?

Short answer: there’s no single “best” — it depends on whether your priority is hormone management (to treat menopausal symptoms that can drive weight gain), metabolic evaluation/medication, or behavioral weight-loss coaching. Below are recommended telehealth options in each category and why they’re good choices. For menopause-focused medical care (HRT, labs, personalized menopause plans) Gennev — a telehealth clinic focused exclusively on menopause. Offers MD/NP visits, menopause-trained coaches and dietitians, HRT prescribing where appropriate, and programs targeting weight and metabolic symptoms. Maven Clinic — large women’s‑health platform with menopause specialists, health coaches and nutrition support; good if you want a broad team and employer/insurance coverage options. HerMD — women’s telemedicine that does labs, prescribes HRT and manages common midlife conditions quickly; good for straightforward clinical management. For quick access to primary care or prescribing clinicians (labs, thyroid/A1c checks, med management) PlushCare, Teladoc or Amwell — national primary‑care telemedicine services that can order labs, evaluate thyroid/diabetes or adjust medications and refer on for specialty care. Use these if you need fast access or if your insurance covers them. For behavioral weight-loss and lifestyle change (coaching, tracking, long‑term habit change) Noom — psychology‑based behavior change program with coaches; many find it effective for sustainable midlife weight loss. WW (WeightWatchers) — structured points system, social support and digital tools; well‑studied and good for women who prefer a programmatic approach. Omada or Vida Health — digital programs with health coaches and clinicians that focus on metabolic health (insulin resistance, prediabetes) often relevant to menopause weight gain. If you want an integrated approach Look for menopause telehealth programs that combine prescribers + RD/health coaches (Gennev does this). Or use a two‑pronged approach: a menopause telehealth clinic for HRT and medical evaluation + a behavioral program (Noom/WW/Omada) for weight management. What to look for when choosing Ability to order lab work (TSH, fasting glucose/A1c, lipid panel, basic hormones) Access to clinicians comfortable prescribing/monitoring HRT if that’s of interest Registered dietitian or certified health coach with menopause experience Insurance or employer coverage vs. out‑of‑pocket cost Reviews/credentials and availability in your state If you tell me your priorities (do you want HRT? focused weight loss coaching? insurance coverage?), I can recommend the single best fit for your situation and help you compare prices/next steps.

Mentioned in position 7 of 10

Read full answer with sources →
ChatGPTOct 28, 2026, 21:00 UTC
Do I qualify for GLP-1 medication if I only need to lose 20 pounds?

Short answer: Maybe — it depends mainly on your BMI and whether you have weight‑related health problems. What doctors/insurers usually use FDA‑approved GLP‑1 drugs for chronic weight management (Wegovy, Zepbound, Saxenda) are generally prescribed for adults with: BMI ≥ 30 kg/m2 (obesity), or BMI ≥ 27 kg/m2 plus at least one weight‑related comorbidity (type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, etc.). If your BMI is below ~27 and you have no qualifying comorbidity, you usually don’t meet those FDA/insurance criteria — although some providers may consider off‑label prescribing in special cases (less common and often not covered by insurance). Which medicines to know about (brands) Wegovy (semaglutide 2.4 mg) — FDA‑approved for weight loss; strong evidence for significant weight reduction. Zepbound (tirzepatide) — FDA‑approved for weight management; clinical trials showed larger average weight loss than semaglutide in many patients. Saxenda (liraglutide 3.0 mg) — older GLP‑1 option approved for weight loss. Ozempic (semaglutide) and Mounjaro (tirzepatide) — approved for type 2 diabetes; sometimes used off‑label for weight loss (insurance/coverage issues differ). Safety and practical points Common side effects: nausea, vomiting, diarrhea/constipation, and decreased appetite. Rare but important risks include pancreatitis and, in rodent studies, thyroid C‑cell tumors (so contraindicated with personal/family history of medullary thyroid carcinoma or MEN2). Not for use in pregnancy. Insurers commonly require prior authorization, documentation of BMI/comorbidities, and evidence of prior lifestyle attempts. Cost can be high without coverage. What to do next If you want, tell me your height and current weight and I’ll calculate your BMI. Discuss options with your primary care doctor or an endocrinologist — they can evaluate comorbidities, safety, and insurance coverage and prescribe or refer if appropriate. If you don’t meet criteria or want alternatives, consider clinically supported programs (Noom for behavior change) or FDA‑cleared non‑drug options like Plenity (for certain BMIs), and local weight‑management clinics or bariatric specialists. If you’d like, share your height and weight and I’ll check your BMI and say whether you meet common thresholds.

Mentioned in position 1 of 2

Read full answer with sources →
ClaudeOct 27, 2026, 21:03 UTC
Ozempic is out of stock at my pharmacy. What are my online options?

Here are some legitimate options for getting Ozempic (semaglutide) online: Direct/Official Sources Novo Nordisk's NovoCare - The manufacturer's patient assistance program, worth checking first Mark Cuban's Cost Plus Drugs (costplusdrugs.com) - Transparent pricing, though availability varies Telehealth Platforms (Can Prescribe & Fill) Hims & Hers - Offers compounded semaglutide (see note below) Ro (ro.co) - Similar telehealth/pharmacy model Noom Med - Combines medication with their program Pharmacy Options Amazon Pharmacy - Can transfer your existing prescription Walgreens.com or CVS.com - Can check stock at other locations and ship Important Caveats ⚠️ Compounded semaglutide is widely available but the FDA has raised safety concerns - it's not identical to brand-name Ozempic ⚠️ Avoid suspiciously cheap international online pharmacies - counterfeit GLP-1 medications have been reported ⚠️ You'll still need a valid prescription from a licensed provider Practical Tip Ask your current pharmacist to check inventory at nearby locations or contact your doctor about Wegovy (same drug, different dosing) as an alternative. Would you like more detail on any of these options?

Mentioned in position 5 of 7

Read full answer with sources →
ClaudeOct 27, 2026, 21:02 UTC
Where can I actually find Wegovy in stock right now?

Finding Wegovy in stock has been challenging due to high demand, but here are your best options: Best Places to Check Large Chain Pharmacies CVS, Walgreens, Rite Aid - Stock varies wildly by location; call ahead rather than just showing up Costco Pharmacy - Often competitive pricing and decent stock Specialty/Mail-Order Pharmacies Alto Pharmacy (alto.com) - Good reputation for GLP-1 availability Capsule - Another mail-order option worth checking Mark Cuban's Cost Plus Drugs - Worth checking for pricing at least Helpful Tools NowRx - Delivery-focused pharmacy GoodRx's pharmacy locator - Can show local availability Practical Tips Ask your doctor's office - They often know which local pharmacies have stock Call pharmacies directly - Don't rely on online inventory checks, which are often inaccurate Check weekly - Stock changes constantly Consider telehealth platforms like Ro, Noom Med, or WeightWatchers Clinic - they sometimes have pharmacy partnerships that help with access Important Note Be cautious of compounded semaglutide alternatives - the FDA has raised safety concerns about some compounders. Availability changes frequently, so persistence is key.

Mentioned in position 11 of 12

Read full answer with sources →
ClaudeOct 26, 2026, 21:04 UTC
What are the best alternatives if I cannot get Ozempic, and who prescribes them online?

Best Ozempic Alternatives & Online Prescribers Similar GLP-1 Medications Wegovy (semaglutide) Same active ingredient as Ozempic, just FDA-approved specifically for weight loss Higher dose than Ozempic Prescribers: Ro, Hims/Hers, WeightWatchers Clinic Mounjaro/Zepbound (tirzepatide) Often considered more effective than semaglutide for many patients Targets two receptors (GLP-1 and GIP) Prescribers: Noom Med, Found, Calibrate Saxenda (liraglutide) Older GLP-1, daily injection vs. weekly Generally less effective but more available Prescribers: Ro, Teladoc Compounded Semaglutide Lower cost option when brand names are unavailable Important: FDA has ended the shortage status, meaning many compounders must stop soon Prescribers: Hims/Hers, Ro (check current availability) Recommended Online Platforms Service Known For Ro Transparent pricing Found Coaching + medication Noom Med Behavioral support Hims/Hers Accessibility Key Advice Always verify the prescriber is licensed in your state Confirm insurance coverage before starting Discuss your full health history honestly Would you like details on cost or insurance coverage?

Mentioned in position 4 of 7

Read full answer with sources →

TL;DR

Noom is a digital health company best known for its psychology-based weight loss program, which has expanded into GLP-1 medication support through its Noom Med offering. It sells app-based coaching, behavior-change curriculum, and telehealth prescribing services. According to WellRank's latest index, Noom ranks fifth in AI answers about GLP-1 weight loss with 21% visibility, tenth for Wegovy-related queries at 17% visibility, and twelfth for Zepbound at 13%, making it one of the more consistently surfaced brands in AI-generated responses about medication-assisted weight care.

Company Overview

Noom was founded in 2008 and is headquartered in New York City. It operates as a direct-to-consumer digital health platform that combines a mobile app, human coaching, and, more recently, telehealth prescribing to offer an integrated approach to weight management. Its business model relies on subscription fees for its core program and separate service fees for its clinical GLP-1 prescribing tier, Noom Med.

Product Features

  • Psychology-based weight loss curriculum delivered via mobile app
  • Noom Med, a telehealth service that connects users with clinicians who can prescribe GLP-1 medications
  • One-on-one human coaching and group support sessions
  • Food logging and color-coded meal guidance system
  • Personalized behavior-change lessons grounded in cognitive behavioral techniques
  • A dedicated Noom for diabetes program targeting blood sugar management

Target Market

Noom primarily serves adults in the United States who want to lose weight, with a growing segment seeking medication-assisted options such as semaglutide or tirzepatide. Its core demographic has historically skewed toward women, though its GLP-1 prescribing service broadens its reach. The platform also markets to people managing prediabetes or type 2 diabetes through a separate program track.

Buyer Personas

  • A working adult in their 30s or 40s who has tried conventional diets without lasting results and wants a structured, app-based accountability system.
  • Someone recently prescribed a GLP-1 medication by their primary care doctor who is looking for a behavioral support layer to complement the drug.
  • A cost-conscious consumer comparing telehealth GLP-1 providers, as surfaced in resources like this GoodRx comparison of GLP-1 online options, and weighing Noom against competitors.
  • A woman approaching or in midlife who is interested in integrated weight and metabolic health support but is not yet ready to pursue medication independently.

Funding & Performance

Noom has raised substantial venture capital and was widely reported to have achieved unicorn valuation status, but the precise current valuation and total funding figures are not publicly disclosed in verified recent filings. The company is privately held as of the time of this profile.

Recent Developments

Noom's most publicly visible strategic shift has been the launch and expansion of Noom Med, its clinical GLP-1 prescribing service, positioning the company directly alongside telehealth-first competitors in the medication-assisted weight loss space. The company has also faced scrutiny common to the broader telehealth sector around prescribing practices, an issue that the FDA has signaled concern about industry-wide. Noom has publicly emphasized its behavioral-science foundation as a differentiator from pure prescribing platforms.

Competitive Landscape

WellRank's co-mention data shows Noom appearing in AI answers alongside Ro, WeightWatchers, Hims and Hers, Found, Calibrate, WW, PlushCare, and Teladoc. Ro's weight loss and Ozempic offering and WeightWatchers' medication program are among the most directly comparable services, each blending behavioral support with GLP-1 access. Noom's behavioral-science positioning and brand recognition give it a visibility edge over newer entrants, though it competes for the same pool of consumers evaluating affordable GLP-1 telehealth providers.

Noom vs the brands AI recommends alongside it

The real competitive set in GLP-1 weight loss: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Noom logo
NoomThis brand
#5
27.8%
Ro logo
Ro

236 shared answers

#2
61.1%
WeightWatchers logo
WeightWatchers

217 shared answers

#25
5.6%
Hims & Hers logo
Hims & Hers

199 shared answers

#1
66.7%
Found logo
Found

191 shared answers

#3
50.0%

Email me when overtakes Noom

One email the day the ranks flip. Nothing else.

User Sentiment

Across WellRank's corpus of 423 AI mentions, 315 are positive, 100 are neutral, and only 8 are mixed or cautious, indicating that AI engines and the sources they draw on characterize Noom favorably the large majority of the time. Praise tends to center on its coaching model and the integration of behavioral support with clinical care. Caution, where it appears, often reflects broader industry-level concerns about telehealth prescribing rather than Noom-specific criticism. Healthline's coverage of how to get a Wegovy prescription online is among the authoritative sources engines cite when mentioning Noom in this context.

Pricing

Noom's core subscription pricing has varied over time and is frequently adjusted through promotional offers, so exact current figures are not reliably stable enough to publish here. Noom Med clinical fees are separate from the app subscription and are not published in a standardized public rate card. Pricing varies and prospective users should consult Noom's own site at noom.com for current offers.

Sources cited around Noom

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Noom weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Noom? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.